Privia Health GroupPRVA
Recorded

Privia Health Group 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration50 minParticipants19

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, and thank you for standing by. Welcome to the Privia Health Q3 2026 conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, you will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Robert Borchert, SVP of Investor and Corporate Communications.

Robert BorchertSVP of Investor and Corporate Communications

Please go ahead. Thank you, Elliot, and good morning, everyone.

Robert BorchertSVP of Investor and Corporate Communications

Joining me are CEO Parth Mehrotra and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed in the investor relations section of priviahealth.com, along with today's press release and slide presentation. Following our prepared comments, we will open the line for questions. Please limit yourself to one question only and return to the queue if you have a follow-up, so we can get to as many questions as possible. Today's reported results are preliminary and are not final until our Form 10-Q for the third quarter and nine-month period ended September 30, 2026, is filed with the Securities and Exchange Commission. Some of our statements today may be forward-looking in nature based on our current expectations and view of our business as of November 5, 2026.

Robert BorchertSVP of Investor and Corporate Communications

Statements such as those related to our future financial and operating performance and future business plans and objectives are subject to risks and uncertainties that may cause actual results to differ materially. These statements should be considered along with our cautionary statements in today's press release and the risk factors described in our most recent SEC filings. Finally, we may refer to certain non-GAAP financial measures on the call, and reconciliation of these measures to comparable GAAP measures are included in our press release and the accompanying slide presentation posted on our website. Now I'd like to hand the call over to our CEO, Parth Mehrotra.

Parth MehrotraCEO

Thank you, Robert, and good morning, everyone. Today, I'll summarize our performance, market presence, and growth strategy, and David will discuss our financial results and updated 2026 guidance before we take your questions. Privia Health continues to demonstrate strong momentum and operational excellence across all aspects of our business. We delivered robust new provider signings, giving us clear visibility into our implementation pipeline for the remainder of 2026 and into 2027. Implemented providers grew 12.2%, and value-based attributed lives increased 19.2% compared to the first nine months of 2025. This drove year-to-date practice collections growth of 12% and adjusted EBITDA growth of 21.9%. EBITDA margin as a percentage of care margin increased to 28.8% as we continue to scale our operating cost structure. Given our strong year-to-date results, we are raising our 2026 outlook above the high end of our initial guidance for all key financial metrics.

Parth MehrotraCEO

Implemented providers are now expected to be at the high end of our initial guidance. We expect to reach 6,000 clinicians by year-end, which is 11.5% growth over 2025. The midpoint of our adjusted EBITDA guidance is now above the high end of our initial guide and represents 23.9% growth over last year. Separately, we are exiting our Montana partnership with Surgery Partners effective January 2027. We support 69 providers and generate approximately $23 million in annual practice collections in the state. This is expected to have no material impact to our adjusted EBITDA in 2027. This week, we announced the acquisition of American Choice Healthcare MSSP ACO, a wholly owned subsidiary of Cano Health, for approximately $36 million in cash. The accountable care organization is expected to care for more than 36,000 attributed lives participating in the Medicare Shared Savings Program beginning January of 2027.

Parth MehrotraCEO

The transaction is expected to have minimal impact on all key metrics in 2026 and positively contribute to attributed lives and adjusted EBITDA in 2027. This will expand the Privia Care Partners VBC footprint in 10 existing states as well as three new states beginning next year. This is a quality addition to our care partners' presence as we continue to supplement our organic growth engine with tuck-in acquisitions. Privia has a highly durable growth algorithm driven by a strong value proposition for community providers across 50-plus specialties, all patient demographics, and payment structures. We have an exceptional sales engine, high retention rates, and a proven track record in value-based care that is resonating very well with our addressable market. We have five core pillars that drive our growth. First, organic growth in existing practices is essential to our value proposition for physician partners.

Parth MehrotraCEO

Our operating teams actively work with practices to expand their patient and provider panels. Our practices also see meaningful operational improvements that drive revenue optimization and practice profitability. This growth scales naturally with each market's expanding care delivery network. Second, organic growth in existing markets through the addition of new care centers continues to be a key driver of growth. Businesses such as clinical research and other ancillary services also drive incremental revenue where we have local and regional density. Third, organic growth in value-based care is supported by increasing attribution as a result of the two prior growth categories, in addition to improving clinical performance in existing programs and entering new value-based contracts. Fourth, our strong balance sheet enables us to deploy capital through acquisitions and partnerships across both new and existing markets. Our business development activities target a variety of assets given our flexible partnership model.

Parth MehrotraCEO

We remain highly opportunistic and disciplined in the current landscape for medical groups and value-based care entities. Finally, we expect to strategically expand our total addressable market by investing in adjacent lines of businesses and new capabilities over time. Ultimately, our goal through these five strategic growth pillars is to build one of the largest community-based care delivery networks in the country that delivers high-quality, low-cost care with exceptional provider satisfaction and patient outcomes. Privia's footprint of community-based medical groups and value-based entities comprises 25 states and the District of Columbia. We now have 5,893 implemented providers caring for over 6.3 million patients in 1,400 care center locations. Our footprint today remains very small subset of our total addressable market of more than 1 million credentialed providers and their underlying patient populations across the country.

Parth MehrotraCEO

This gives us the confidence to continue to compound growth across our key operating and financial metrics for many years to come. Privia now serves over 1.67 million attributed lives in value-based arrangements across more than 130 commercial, Medicare Advantage, and Medicaid programs. Commercial attributed lives increased 11.8% from last year to reach 966,000. Lives attributed to the CMS Medicare programs were up 59%. Medicare Advantage and Medicaid attribution increased 12.6% and 12.7% respectively. The balance and diversification of Privia's providers and payer contracts gives us the confidence in our ability to build scale and profitability without depending on any one particular program. David will now review our recent financial results, balance sheet strength, and our updated 2026 guidance in more detail.

David MountcastleCFO

Thank you, Parth. Privia Health's strong operational execution and growth continued through the third quarter. Implemented providers grew 249 sequentially from Q2 to reach 5,893 at September 30th, an increase of 12.2% year-over-year. Implemented provider growth, as well as strong ambulatory utilization trends and value-based performance, led to year-to-date practice collections growing 12% from a year ago to reach $2.91 billion. Adjusted EBITDA, which is reconciled to GAAP net income in the appendix, increased 21.9% over the first nine months last year to reach $114.7 million, or 28.8% of care margin. This highlights our highly predictable revenue and care margin engine, with operating leverage across both cost of platform and G&A to generate strong EBITDA margins while investing across all markets. We ended the third quarter with $446.3 million in cash and no debt.

David MountcastleCFO

We expect approximately 70% of full-year adjusted EBITDA to convert to free cash flow and expect to end the year with at least $520 million in cash on our balance sheet. This accounts for the American Choice Healthcare transaction and assumes the 2025 MSSP cash settlement and related provider disbursements occur before year-end based on our current accruals. This does not include any potential additional capital deployment for business development. Our core financial outlook remains very strong, and we look forward to CMS delivering final MSSP 2025 performance results this month. Our strong year-to-date performance has provided us with excellent visibility and confidence to raise our 2026 outlook above the high end of initial guidance across all key financial metrics. Implemented providers are now expected to reach the high end of our initial guidance of 6,000 clinicians.

David MountcastleCFO

Using the midpoints of our new 2026 guidance, attributed lives growth is expected to increase 9.2% over 2025. We expect practice collections to grow 13.1% and care margin 16.3% at their respective midpoints. We are also guiding to adjusted EBITDA growth of 23.9% at the midpoint. Privia Health continues to drive consistent, sustainable growth and profitability given our differentiated business, consistent execution, and compounding economic model. Our consistent track record over the past nine years across economic, political, and regulatory cycles speaks to the strength and durability of our business. We look forward to continuing to serve our clinicians and their patients on our long-term journey together. Operator, we are now ready to take questions.

Operator

Thank you. At this time, we will conduct the question-and-answer session. As a reminder, to ask a question, you will need to press star 11 on your telephone and wait for your name to be announced. To withdraw your question, please press star 11 again. Please stand by while we compile the Q&A roster. Our first question comes from the line of Elizabeth Anderson of Evercore ISI. Your line is now open.

Elizabeth AndersonAnalyst

Hi, guys. Good morning, and thanks for the question. As we think about your recent acquisition of American Choice, can you talk about where you see the specific opportunities? Why was that a good fit for Privia? Then maybe a little bit more zooming out a little bit, like obviously with the Montana exit and maybe there were some specific dynamics there. I guess, what in your experiences you've had more time sort of makes things sort of a good or maybe not a less good fit?

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day